Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies rhAmpSeq CRISPR Analysis System

Integrated DNA Technologies has launched its rhAmpSeq CRISPR Analysis System, an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.

The system uses proprietary IDT rhAmpSeq technology, which enables highly accurate amplicon sequencing on Illumina next-generation sequencing platforms. The rhAmpSeq CRISPR Analysis System consists of design and synthesis of a custom rhAmpSeq CRISPR Panel, an efficient library kit, and access to data analysis through a user-friendly interface. Starting from sample, it can provide results in less than a week, IDT said.

It also includes IDT's rhAmpSeq CRISPR Analysis Tool, a cloud-based data analysis pipeline that produces publication-ready graphs and figures. This comprehensive analysis tool is hosted by BlueBee, an Illumina company. 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.